A QSAR STUDY OF SUBSTITUTED PYRAZOLINE DERIVATIVES AS POTENTIAL ANTI-TUBERCULOSIS AGENTS

A quantitative structure–activity relationship (QSAR) of a series of substituted pyrazoline derivatives, in regard to their anti-tuberculosis activity, has been studied using the partial least square (PLS) analysis method. QSAR model development of 64 pyrazoline derivatives was carried out to predict anti-tubercular activity. Partial least square analysis was applied to derive QSAR models, which were further evaluated for statistical significance and predictive power by internal and external validation. The best QSAR model with good external and internal predictivity for the training and test set has shown cross validation (q2) and external validation (pred_r2) values of 0.7426 and 0.7903, respectively. Two-dimensional QSAR analyses of such pyrazoline derivatives provide important structural insights for designing potent antituberculosis drugs.